Data protection Impressum

Life sciences

ten23 health celebrates the opening of its VIVA2® facility in Visp, increasing the region's sterile pharmaceutical production capacity and strengthening its position in the life sciences sector.

ten23 health inaugurates VIVA2 sterile production facility in Visp

24 September 2024

Novostia has raised CHF 5.6 million in a new financing round and appointed Soad El Ghazouani as CEO to accelerate the development of its TRIFLO heart valve technology.

Novostia secures CHF 5.6 million to accelerate the development of its heart valve

24 September 2024

Neo Medical has raised USD 68 million in a Series B financing round to accelerate the global growth of its AI-driven spine surgery solutions, with a focus on the US market.

Neo Medical secures USD 68 million to expand its AI-powered spine surgery platform

24 September 2024

The CHUV in Lausanne has inaugurated the state-of-the-art Swiss BioMotion Lab, which offers innovative solutions for the study and treatment of osteoarthritis through cutting-edge motion analysis.

CHUV inaugurates Swiss BioMotion Lab for advanced osteoarthritis research and treatment

23 September 2024

Actival, a start-up supported by CSEM, has developed 3D-printed transparent aligners with antibacterial microchannels, setting a new standard in dental hygiene.

Actival and CSEM launch 3D-printed antibacterial dental aligners

23 September 2024

Distalmotion, the Vaud-based medtech behind the Dexter robotic system, has completed a financing round led by Revival Healthcare and the Swiss Entrepreneurs Fund, marking a major step in the company's commercial growth phase.

Distalmotion secures new capital to drive the global expansion of its Dexter surgical robot

18 September 2024

ONWARD Medical has secured a USD 1.1 million grant from the Christopher & Dana Reeve Foundation to further develop its ARC-BCI system, which aims to restore thought-controlled movement to people with spinal cord injuries.

ONWARD Medical awarded USD 1.1 million by the Christopher & Dana Reeve Foundation

17 September 2024

HAYA Therapeutics has announced a multi-year collaboration with Eli Lilly, potentially earning up to USD 1 billion in milestone payments to advance RNA-guided therapies for obesity and metabolic disorders.

HAYA Therapteutics enters major collaboration to advance RNA-based drug discovery

17 September 2024

LEM Surgical, a leader in surgical robotics, has opened a state-of-the-art 19,400-square-foot headquarters in Bern, Switzerland.

LEM Surgical unveils new headquarters in Bern to advance surgical robotics

3 September 2024

Biotech Vandria has raised an additional CHF 14 million to accelerate the development of innovative treatments for age-related and chronic diseases, bringing its total Series A financing to CHF 28.3 million.

Vandria secures over CHF 14 million to advance age-related disease therapies

3 September 2024

1 … 4 5 6 7 8 9 10 11 12 … 41